wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37324772-E140CAFE-09B0-4457-928A-67FDAD5A7BBF
Q37324772-E140CAFE-09B0-4457-928A-67FDAD5A7BBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37324772-E140CAFE-09B0-4457-928A-67FDAD5A7BBF
Drugs in early clinical development for Systemic Lupus Erythematosus.
P2860
Q37324772-E140CAFE-09B0-4457-928A-67FDAD5A7BBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37324772-E140CAFE-09B0-4457-928A-67FDAD5A7BBF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
743468d3203a76eeebe6f6158c5aca3f1269b9b8
P2860
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study.